Silencing of signal transducer and activator of transcription 3 expression by RNA interference suppresses growth of human hepatocellular carcinoma in tumor-bearing nude mice

AIM:To explore the effect of silencing of signal transducer and activator of transcription 3(STAT3) expression by RNA interference(RNAi) on growth of human hepatocellular carcinoma(HCC) in tumor-bearing nude mice in vivo.METHODS:To construct the recombinant plasmid of pSilencer 3.0-H1-STAT3-siRNA-GFP(pSH1-siRNA-STAT3) and establish the tumor-bearing nude mouse model of the HCC cell line SMMC7721,we used intratumoral injection together with electroblotting to transfect the recombinant plasmid pSH1-siRNA-STAT3 into the transplanted tumor.The weight of the nude mice and tumor volumes were recorded.STAT3 gene transcription was detected by semi-quantitative reverse transcription polymerase chain reaction(RTPCR).Level of protein expression and location of STAT3 were determined by Western blotting and immunohistochemical staining.STAT3-related genes such as survivin,c-myc,VEGF,p53 and caspase3 mRNA and protein expression were detected in tumor tissues at the same time.The terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling(TUNEL) assay was used to detect apoptosis of tumor cells.RESULTS:The weight of the treated nude mice increased,and the tumor volume decreased markedly compared with those of the mock-treated and negative control groups(P < 0.01).The results of RT-PCR and Western blotting showed that mRNA and protein levels of STAT3 declined markedly in the treated group.The change in STAT3-related gene expression in tumor tissues at the mRNA and protein level also varied,the expression of survivin,VEGF and c-myc were obviously reduced,and expression of p53 and caspase3 increased(P < 0.01).Most of the tumor tissue cells in the treated group developed apoptosis that was detected by TUNEL assay.CONCLUSION:Silencing of STAT3 expression by RNAi significantly inhibits expression of STAT3 mRNA and protein,and suppresses growth of human HCC in tumor-bearing nude mice.The mechanism may be related to down-regulation of survivin,VEGF and c-myc and up-regulation of p53 and caspase3 expression.Accordingly,the STAT3 gene may act as an important and effective target in gene therapy of HCC.

Relationship and significance between anti-b2-glycoproteinⅠantibodies and platelet activation state in patients with ulcerative colitis

AIM:To study the relationship between anti-b2-glycoprotein Ⅰ (ab2GPⅠ) antibodies and platelet activation state in patients with ulcerative colitis (UC) and its significance. METHODS:Peripheral blood samples were collected from 56 UC patients (34 males and 22 females, aged 43.5 years, range 21-66 years), including 36 at active stage and 20 at remission stage, and 25 sex-and age-matched controls. The level of ab2GPⅠ was measured by ELISA. The platelet activation markers, platelet activation complex-Ⅰ (PAC-Ⅰ) and P-selectin (CD62P) were detected by flow cytometry. RESULTS:The A value for IgG ab2GPⅠ in the active UC group was 0.61 ± 0.13, significantly higher than that in the remittent UC and control groups (0.50 ± 0.13 and 0.22 ± 0.14, P < 0.01). There was a significant difference between the two groups (P < 0.01). The A value for IgM ab2GPⅠ in the active and remittent UC groups was 0.43 ± 0.13 and 0.38 ± 0.12, significantly higher than that in the control group (0.20 ± 0.12, P < 0.01). However, there was no significant difference between the two groups (P > 0.05). The PAC-Ⅰ positive rate for the active and remittent UC groups was 30.6% ± 7.6% and 19.6% ± 7.8% respectively, significantly higher than that for the control group (6.3% ± 1.7%, P < 0.01). There was a significant difference between the two groups (P < 0.01). The CD62P positive rate for the active and remittent UC groups was 45.0% ± 8.8% and 31.9% ± 7.8% respectively, significantly higher than that for the control group (9.2% ± 2.7%, P < 0.01). There was a significant difference between the two groups (P < 0.01). In the active UC group, the more severe the state of illness was, the higher the A value for IgG ab2GPⅠ was, and the positive rate for PAC-I and CD62P was positively correlated with the state of illness (Fab2GPⅠ = 3.679, P < 0.05;FPAC-I (%) = 5.346, P < 0.01;and FCD62P (%) = 5. 418, P < 0.01). Meanwhile, in the same state of illness, the A value for IgG ab2GPⅠ was positively correlated to the positive rates for PAC-I and CD62P. CONCLUSION:ab2GPⅠ level, platelet activation state and their relationship of them are closely correlated with the pathogenesis and development of UC.